Pure Global

BD MAX Clostridium difficile detection reagent - Taiwan Registration 35dbd32b56bcbcfc16bfa3d6d19880ca

Access comprehensive regulatory information for BD MAX Clostridium difficile detection reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 35dbd32b56bcbcfc16bfa3d6d19880ca and manufactured by BECTON DICKINSON AND COMPANY;; GeneOhm Sciences Canada, ULC.. The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).

This page provides complete technical specifications, regulatory compliance details, 2 companies making similar products including GENEOHM SCIENCES CANADA, INC., Benex Limited;; GeneOhm Sciences Canada, ULC., and 2 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
2 Competitors
2 Recent Registrations
35dbd32b56bcbcfc16bfa3d6d19880ca
Registration Details
Taiwan FDA Registration: 35dbd32b56bcbcfc16bfa3d6d19880ca
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

BD MAX Clostridium difficile detection reagent
TW: BD MAXๅ›ฐ้›ฃๆขญ็‹€่Šฝๅญขๆกฟ่Œๆชขๆธฌ่ฉฆๅŠ‘
Risk Class 2

Registration Details

35dbd32b56bcbcfc16bfa3d6d19880ca

DHA05603467701

Product Details

Used with the BD MAX System, this product is an automated in vitro diagnostic reagent for the direct qualitative detection of Clostridium difficile toxin B gene (tcdB) in human fluids or soft stool samples from patients suspected of Clostridium difficile infection (CDI). This is a test performed directly on the sample using real-time polymerase chain reaction (PCR) to amplify the DNA DNA of the Clostridium difficile toxin B gene and detect amplified DNA with fluorescent target-specific hybridization probes. This product is intended to assist in the diagnosis of Clostridium difficile infection (CDI).

C Immunology and microbiology

C.3130 ๅ›ฐ้›ฃๆขญ็‹€ๆกฟ่Œๆฏ’็ด ๅŸบๅ› ๆ“ดๅขž่ฉฆๅŠ‘

Input;; QMS/QSD

Dates and Status

Jul 15, 2021

Jul 15, 2026

Companies Making Similar Products
Top companies providing products similar to "BD MAX Clostridium difficile detection reagent"